Is Auxesis Pharma a legitimate company?
Yes. Auxesis Pharma is a Swedish research and development company within life science. The company operates under applicable regulations and all share issuances are registered according to Swedish law.
Investors
Investor Information
Here we answer common questions about investing in Auxesis Pharma and how shares are registered.
How do share issuances work?
Auxesis Pharma finances its operations through share issuances, which is standard for companies in early-stage development. The capital is used for research, development and clinical studies.
Why are shares not visible in my bank account?
Unlisted shares are registered via Euroclear and are not always displayed in the same way as publicly traded shares.
What is Euroclear?
Euroclear Sweden is the system where Swedish shares are registered and ownership is recorded.
Why does the value show as 0?
Unlisted shares do not have a daily market valuation and are therefore often displayed as 0 in banking systems.
Does Auxesis Pharma plan to go public?
The company has evaluated a listing but has chosen to wait until the commercial phase is established, in order to ensure long-term shareholder value.
Investor Information
Structured and long-term strategy
Auxesis Pharma is a Swedish research and development company within life science. The company finances its operations through share issuances, which is standard in this stage of pharmaceutical development. Historically, issuances have been conducted via external partners in accordance with applicable regulations, and the capital has been used for research and development. The company has chosen to postpone a stock market listing until the commercial phase is established, ensuring stable growth and long-term shareholder value. The current focus is on clinical studies and future commercialization.